Matches in Wikidata for { <http://www.wikidata.org/entity/Q94504038> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q94504038 description "article scientifique publié en 2020" @default.
- Q94504038 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94504038 description "scientific article published on 03 May 2020" @default.
- Q94504038 description "wetenschappelijk artikel" @default.
- Q94504038 description "наукова стаття, опублікована 3 травня 2020" @default.
- Q94504038 name "Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study" @default.
- Q94504038 name "Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study" @default.
- Q94504038 type Item @default.
- Q94504038 label "Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study" @default.
- Q94504038 label "Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study" @default.
- Q94504038 prefLabel "Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study" @default.
- Q94504038 prefLabel "Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study" @default.
- Q94504038 P1433 Q94504038-C64A4FF3-3128-4E14-95CF-7181C8348E98 @default.
- Q94504038 P1476 Q94504038-AF1EE6D4-BFE2-4CAB-897E-C346CDE57411 @default.
- Q94504038 P2093 Q94504038-12F164F3-E839-4E0C-9936-55C2C9D7ECB4 @default.
- Q94504038 P2093 Q94504038-2E37F393-096D-4747-9509-14B31A4E947A @default.
- Q94504038 P2093 Q94504038-6C27D4D7-4E44-4562-9E2B-6DB0DC377DC2 @default.
- Q94504038 P2093 Q94504038-81DA871F-0F1C-4F7D-8C71-C42E5C5BFC40 @default.
- Q94504038 P2093 Q94504038-B05ACD8E-0A6A-4260-BF5C-D9F7DABAA827 @default.
- Q94504038 P2093 Q94504038-CD2ABAB6-C5F3-4E1E-8C0A-4710D6CAA404 @default.
- Q94504038 P2093 Q94504038-D16A0F32-6D2B-45E9-8CA2-88BBF469B87B @default.
- Q94504038 P2093 Q94504038-DF932D11-F13C-4FDF-9BBB-1144F6E75949 @default.
- Q94504038 P2093 Q94504038-F0A0BB3A-EFB9-4D15-ACEA-1EAD45616EDF @default.
- Q94504038 P2093 Q94504038-F6C8CCB6-72E7-4DCE-8401-1903D3394C13 @default.
- Q94504038 P31 Q94504038-B36D2F31-6A3E-4FF8-90DE-8D9B15953E03 @default.
- Q94504038 P356 Q94504038-CE11FB8C-55B1-4D01-8808-9BD63D8AB18F @default.
- Q94504038 P577 Q94504038-209B5361-D2B5-411D-B720-C7EF107096C2 @default.
- Q94504038 P698 Q94504038-10BAF051-B35B-46AD-866F-F3D5F9871F3F @default.
- Q94504038 P932 Q94504038-ECD4B8C0-0AA3-4BEA-A4E4-F3D509A2AC07 @default.
- Q94504038 P356 S10637-020-00925-2 @default.
- Q94504038 P698 32363427 @default.
- Q94504038 P1433 Q2312231 @default.
- Q94504038 P1476 "Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study" @default.
- Q94504038 P2093 "Fangwen Zhang" @default.
- Q94504038 P2093 "Fei Kong" @default.
- Q94504038 P2093 "Jingjing Wu" @default.
- Q94504038 P2093 "Lei Zhang" @default.
- Q94504038 P2093 "Liangliang Ren" @default.
- Q94504038 P2093 "Ling Li" @default.
- Q94504038 P2093 "Mingzhi Zhang" @default.
- Q94504038 P2093 "Xiaorui Fu" @default.
- Q94504038 P2093 "Xin Li" @default.
- Q94504038 P2093 "Xinhua Wang" @default.
- Q94504038 P31 Q13442814 @default.
- Q94504038 P356 "10.1007/S10637-020-00925-2" @default.
- Q94504038 P577 "2020-05-03T00:00:00Z" @default.
- Q94504038 P698 "32363427" @default.
- Q94504038 P932 "7575486" @default.